search
Back to results

Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial (EPCentCare)

Primary Purpose

Dementia

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Person-centered Care
Optimised Treatment
Sponsored by
Martin-Luther-Universität Halle-Wittenberg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Dementia focused on measuring nursing homes, person-centered care, inappropriate prescriptions, cluster-randomised controlled trial, antipsychotic drugs

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

On cluster level

Inclusion Criteria:

  • nursing homes with at least 50 residents

Exclusion Criteria:

  • other ongoing trial in the institution

On individual level

Inclusion Criteria:

  • all residents within a cluster are eligible to participate in the study

Exclusion Criteria:

  • diagnoses of schizophrenia, schizoaffective psychosis, or other forms of primary psychosis
  • respite care

Sites / Locations

  • Universität Witten/Herdecke
  • Martin-Luther-Universität Halle-Wittenberg
  • University of Luebeck

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Person-centered Care

Optimised Treatment

Arm Description

Medication Review + Person-centered Care

Medication Review

Outcomes

Primary Outcome Measures

Proportion of residents receiving at least one antipsychotic medication after 12 months

Secondary Outcome Measures

Residents' quality of life
Will be measured with the QoL-AD
Behavioural and psychological symptoms of dementia
Will be measured with the CMAI
Costs within trial period
Cost parameters will be collected alongside the trial on intervention-related components as well as outcome-related components. Costs which are explicitly trial-associated will not be taken into account for cost analysis.
Falls and fall-related medical attention
Physical restraints within study period
Physical restraints will be assessed retrospectively by data extraction from residents' records- The following devices will be assessed: bilateral bedrails, belts, fixed tables, and other measures limiting free body movement.
Median daily dose of antipsychotics in chlorpromazine equivalents within study period
Each resident's daily dose of antipsychotic drugs will be translated into chlorpromazine daily equivalents.

Full Information

First Posted
November 12, 2014
Last Updated
May 2, 2017
Sponsor
Martin-Luther-Universität Halle-Wittenberg
Collaborators
University of Luebeck, University of Witten/Herdecke
search

1. Study Identification

Unique Protocol Identification Number
NCT02295462
Brief Title
Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial
Acronym
EPCentCare
Official Title
Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
December 2014 (undefined)
Primary Completion Date
February 2017 (Actual)
Study Completion Date
February 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Martin-Luther-Universität Halle-Wittenberg
Collaborators
University of Luebeck, University of Witten/Herdecke

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Background: Up to 90% of nursing home residents with dementia experience behavioural and psychological symptoms like apathy, agitation, and anxiety. According to analyses of prescription prevalence in Germany, antipsychotic drugs seem to be prescribed as first line treatment of neuropsychiatric symptoms in persons with dementia. A huge number is prescribed for inappropriate reasons and too long without regular review. The use of antipsychotics is associated with adverse events like increased risk of falling, stroke, and mortality. This study aims to investigate whether a person-centered care approach developed in the United Kingdom can be adapted and implemented in German nursing homes. The aim of the investigators trial is to achieve a clinically relevant reduction of the proportion of residents with alt least one antipsychotic drug prescription. Methods/Design: Cluster-randomised controlled trial comparing an intervention group (two-day initial skill training on person-centred care and on-going training and support programme) with a control group receiving optimised usual care. Both study groups will receive a medication review by an experienced psychiatrist with feedback to the prescribing physician. Overall, 36 nursing homes from East, North and West Germany will be included and randomised. The primary outcome is defined as the proportion of residents receiving at least one antipsychotic medication at 12 months. Secondary outcomes are residents' quality of life, behavioural and psychological symptoms of dementia as well as safety parameters like falls and fall-related medical attention. Cost parameters will be collected and process evaluation will be performed alongside the trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dementia
Keywords
nursing homes, person-centered care, inappropriate prescriptions, cluster-randomised controlled trial, antipsychotic drugs

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
1158 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Person-centered Care
Arm Type
Experimental
Arm Description
Medication Review + Person-centered Care
Arm Title
Optimised Treatment
Arm Type
Active Comparator
Arm Description
Medication Review
Intervention Type
Other
Intervention Name(s)
Person-centered Care
Intervention Description
Medication Review + Person-centered Care
Intervention Type
Other
Intervention Name(s)
Optimised Treatment
Intervention Description
Medication Review only
Primary Outcome Measure Information:
Title
Proportion of residents receiving at least one antipsychotic medication after 12 months
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Residents' quality of life
Description
Will be measured with the QoL-AD
Time Frame
12 months
Title
Behavioural and psychological symptoms of dementia
Description
Will be measured with the CMAI
Time Frame
12 months
Title
Costs within trial period
Description
Cost parameters will be collected alongside the trial on intervention-related components as well as outcome-related components. Costs which are explicitly trial-associated will not be taken into account for cost analysis.
Time Frame
12 months
Title
Falls and fall-related medical attention
Time Frame
12 months
Title
Physical restraints within study period
Description
Physical restraints will be assessed retrospectively by data extraction from residents' records- The following devices will be assessed: bilateral bedrails, belts, fixed tables, and other measures limiting free body movement.
Time Frame
12 months
Title
Median daily dose of antipsychotics in chlorpromazine equivalents within study period
Description
Each resident's daily dose of antipsychotic drugs will be translated into chlorpromazine daily equivalents.
Time Frame
12 months
Other Pre-specified Outcome Measures:
Title
Process evaluation
Description
Different methods will be used for data collection: investigators documentation, questionnaires on staff knowledge and self-efficacy, structured interviews and in depth-interviews with staff.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
On cluster level Inclusion Criteria: nursing homes with at least 50 residents Exclusion Criteria: other ongoing trial in the institution On individual level Inclusion Criteria: all residents within a cluster are eligible to participate in the study Exclusion Criteria: diagnoses of schizophrenia, schizoaffective psychosis, or other forms of primary psychosis respite care
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gabriele Meyer, Prof. Dr.
Organizational Affiliation
Martin-Luther-Universität Halle-Wittenberg
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universität Witten/Herdecke
City
Witten Herdecke
State/Province
Nordrhein-Westfalen
ZIP/Postal Code
58448
Country
Germany
Facility Name
Martin-Luther-Universität Halle-Wittenberg
City
Halle (Saale)
State/Province
Sachsen-Anhalt
ZIP/Postal Code
06110
Country
Germany
Facility Name
University of Luebeck
City
Lübeck
State/Province
Schleswig-Holstein
ZIP/Postal Code
23562
Country
Germany

12. IPD Sharing Statement

Citations:
PubMed Identifier
35804407
Citation
Richter C, Fleischer S, Langner H, Meyer G, Balzer K, Kopke S, Sonnichsen A, Loscher S, Berg A. Factors influencing the implementation of person-centred care in nursing homes by practice development champions: a qualitative process evaluation of a cluster-randomised controlled trial (EPCentCare) using Normalization Process Theory. BMC Nurs. 2022 Jul 8;21(1):182. doi: 10.1186/s12912-022-00963-6.
Results Reference
derived
PubMed Identifier
30806453
Citation
Richter C, Berg A, Langner H, Meyer G, Kopke S, Balzer K, Wolschon EM, Silies K, Sonnichsen A, Loscher S, Haastert B, Icks A, Wolf U, Fleischer S. Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): a cluster-randomised controlled trial. Age Ageing. 2019 May 1;48(3):419-425. doi: 10.1093/ageing/afz016.
Results Reference
derived
PubMed Identifier
29914389
Citation
Dichter MN, Wolschon EM, Schwab CGG, Meyer G, Kopke S. Item distribution and inter-rater reliability of the German version of the quality of life in Alzheimer's disease scale (QoL-AD) proxy for people with dementia living in nursing homes. BMC Geriatr. 2018 Jun 19;18(1):145. doi: 10.1186/s12877-018-0834-z.
Results Reference
derived
PubMed Identifier
26037324
Citation
Richter C, Berg A, Fleischer S, Kopke S, Balzer K, Fick EM, Sonnichsen A, Loscher S, Vollmar HC, Haastert B, Icks A, Dintsios CM, Mann E, Wolf U, Meyer G. Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial. Implement Sci. 2015 Jun 4;10:82. doi: 10.1186/s13012-015-0268-3.
Results Reference
derived

Learn more about this trial

Effect of Person-Centred-Care on Antipsychotic Drug Use in Nursing Homes: a Cluster-randomised Trial

We'll reach out to this number within 24 hrs